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Two-step activation of FOXO3 by AMPK generates a
coherent feed-forward loop determining excitotoxic
cell fate
D Davila1, NMC Connolly2, H Bonner1, P Weisova´1,3, H Dussmann1,2, CG Concannon1,2, HJ Huber2 and JHM Prehn*,1,2
Cerebral ischemia and excitotoxic injury induce transient or permanent bioenergetic failure, and may result in neuronal
apoptosis or necrosis. We have previously shown that ATP depletion and activation of AMP-activated protein kinase (AMPK)
during excitotoxic injury induces neuronal apoptosis by transcription of the pro-apoptotic BH3-only protein, Bim. AMPK,
however, also exerts pro-survival functions in neurons. The molecular switches that determine these differential outcomes are
not well understood. Using an approach combining biochemistry, single-cell imaging and computational modeling, we here
demonstrate that excitotoxic injury activated the bim promoter in a FOXO3-dependent manner. The activation of AMPK reduced
AKT activation, and led to dephosphorylation and nuclear translocation of FOXO3. Subsequent mutation studies indicated that
bim gene activation during excitotoxic injury required direct FOXO3 phosphorylation by AMPK in the nucleus as a second
activation step. Inhibition of this phosphorylation prevented Bim expression and protected neurons against excitotoxic and
oxygen/glucose deprivation-induced injury. Systems analysis and computational modeling revealed that these two activation
steps defined a coherent feed-forward loop; a network motif capable of filtering any effects of short-term AMPK activation on bim
gene induction. This may prevent unwanted AMPK-mediated Bim expression and apoptosis during transient or physiological
bioenergetic stress.
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Excitotoxicity has been implicated in the pathogenesis of
cerebral ischemia and several neurodegenerative disor-
ders,1–3 and results from abnormal levels of the excitatory
neurotransmitter glutamate (GLUT) in the synaptic cleft.4-6
The extent of ATP depletion during excitotoxic injury critically
determines neuronal outcome.7 Neurons that fail to restore
their ATP levels undergo rapid excitotoxic necrosis.7 How-
ever, many of the neurons that initially overcome the energetic
crisis and recover their ATP levels nevertheless undergo a
delayed apoptotic death.8 ATP depletion activates the AMP-
activated protein kinase (AMPK), which adapts the cellular
response to bioenergetic stress.9 AMPK switches off anabolic
pathways, preventing ATP consumption, and switches on
catabolic pathways, increasing glucose uptake and ATP
production.10 AMPK-dependent plasma membrane translo-
cation of the glucose transporter 3, and subsequent glucose
uptake mediate tolerance of neurons to excitotoxic or
ischemic injury.11,12 In contrast to these cytoprotective
mechanisms, however, prolonged AMPK activation has also
been shown to contribute to ischemic injury and excito-
toxicity.9,13,14 We recently demonstrated that prolonged
activation of AMPK mediates excitotoxic apoptosis by indu-
cing the expression of the pro-apoptotic Bcl-2 family protein
Bim.13 However, the mechanisms that AMPK utilizes to switch
on the transcriptional activation of bim during excitotoxic
apoptosis remain unknown. Here, we describe the signaling
pathways that couple AMPK activation to bim gene expres-
sion during excitotoxic apoptosis, and provide a mathematical
framework that explains cell fate decision-making during
AMPK activation.
Results
Bim induction during excitotoxic apoptosis requires
AP-1 and FOXO3. We have previously shown that brief
stimulation of NMDA receptors in cortical neurons or cere-
bellar granule neurons (CGNs) induces a bim-dependent,
delayed excitotoxic cell death characteristic of caspase-
independent apoptosis.11,13,15 Western blot (Figure 1a) and
qPCR analysis confirmed that CGNs exposed to GLUT/
glycine (GLY) (100/10 mM) showed elevated Bim levels.
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Excitotoxic injury was significantly reduced in CGNs deficient
in bim (Figure 1b).
We next addressed the signaling pathways involved in bim
activation during excitotoxic injury. Excellent candidates are
the FOXO3 and AP-1 transcription factors, which have been
implicated in Bim expression during neuronal apopto-
sis.13,16–18 We transfected CGNs with a reporter construct
bearing the wild-type (wt) bim promoter sequence, or bim
promoter constructs harboring mutations in the FOXO3 or AP-1
binding sites. Luciferase activity was significantly increased
in GLUT-treated neurons expressing the wt bim promoter.
However, this effect was abrogated by either bim promoter
mutation (Figure 1c), indicating that FOXO3 and AP-1 binding
sites were necessary for bim promoter activation.
AMPK-dependent downregulation of the mTOR/AKT
pathway during excitotoxicity. Previously, we demon-
strated that pAMPK activated JNKs, with JNK activation
contributing to bim expression and apoptosis.13 We therefore
next focused on exploring the role of FOXO3 activation in bim
gene induction, and its control by AMPK. Firstly, we analyzed
AMPK activation during excitotoxicity by western blot
analysis of pAMPKa (Thr172) levels. AMPK activation was
evident 10 min after GLUT exposure, and recovered to
baseline levels after 120 min (Figure 2a).
The mTOR kinase complex (mTORC) is negatively
regulated by AMPK.19 To address the regulation of mTORC
during excitotoxicity, we monitored phospho-mTOR
(Ser2448) levels (Figure 2b). GLUT treatment decreased
p-mTOR levels 10 min after exposure, coinciding with the
peak of AMPK activation. Notably, p-mTOR levels were
persistently downregulated in response to GLUT. mTORC2
has been described as an important activator of the pro-
survival kinase AKT.20 We detected an early decrease in
pAKT (Ser473) levels in response to GLUT (Figure 2c). In
contrast to p-mTOR, however, pAKT levels partially recov-
ered 2–8 h after GLUT exposure with complete recovery after
16/24 h. The inactivation of AKT enables FOXO3-dependent
gene transcription by preventing the cytosolic translocation of
FOXO3.21 Western blot analysis of phospho-FOXO3 (Thr32)
levels showed a significant decrease 2–4 h after GLUT
exposure (Figure 2d).
To demonstrate that AMPK activation was responsible for
the decrease in pAKT levels during excitotoxic injury,
we depleted AMPK levels with vectors expressing an
siRNA targeting AMPK-a1/a2, or a control sequence13
(Supplementary Figure 1). CGNs with depleted AMPK levels
presented significantly higher levels of phospho-AKT
(Ser473) compared with control-transfected neurons
(Figure 2e). This result was confirmed using the pharmaco-
logical inhibitor of AMPK, compound C (CC). CGNs pre-
treated with CC (10 mM) 45 min before GLUT exposure
presented with 69.5±19.5% higher phospho-AKT (Ser473)
levels 30 min after GLUT treatment, compared with those
pretreated with vehicle (data not shown). AMPK-a1/a2
depletion also increased phospho-FOXO3 (Thr32) levels in
neurons exposed to GLUT (Figure 2e). Confirming the
downregulation of FOXO3 phosphorylation by AMPK,
transfection of CGNs with a constitutively active mutant
of AMPK (AMPK-CA) resulted in a decrease in phospho-
FOXO3 (Thr32) levels and an increase in Bim expression
(Supplementary Figures 2A and B). Finally, to demonstrate
that FOXO3 dephosphorylation was a consequence of AKT
downregulation, we transfected CGNs with a constitutively
Bim promoter AP-1 site mutated
Bim promoter FOXO3 site mutated
Bim promoter Wild Type 
Glut / Gly (100/10 μM)
Lu
ci
fe
ra
se
 re
po
rte
r a
ct
ivi
ty
(F
old
 in
cre
as
e)
*
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
- - - + + +
+ - - + - -
- + - - + -
- - + - - +
0
100
200
300
Bim
β-Actin
*
O
pt
ica
l D
en
sit
y
(%
 of
 co
ntr
ol)
Sham 24 h
Time after glutamate treatment
Sham Glut/Gly
WT
bim -/-
Sham
%
 P
yk
no
tic
 n
u
cl
e
i
0
20
40
60
80
100
*
WT
bim -/-
*
**
Glut/Gly
4 h2 h30’10’ 8 h 16 h
a
b
c
Figure 1 Bim induction during excitotoxic apoptosis requires AP-1 and FOXO3.
(a) Western blot analysis showed a significant increase in Bim levels within a 4–24 h
time frame after GLUT/GLY (100mM/10mM, 30 min) exposure (*Po0.05; n¼ 5).
b-actin served as loading control. (b) CGNs from bim / mice and wt controls
were treated with GLUT or experimental buffer (sham conditions). 24 h after
treatment the neurons were stained live with Hoechst and pyknotic nuclei scored
(*Po0.05; n¼ 3). Bar, 2.5mm. (c) CGNs were transfected with a vector containing
a 0.8 kB fragment of the bim promoter. Bim promoter activation was significantly
increased 24 h after GLUT exposure (*Po0.05; n¼ 3). Mutations of the FOXO3
and AP-1 binding sites significantly reduced this activation (*Po0.05; n¼ 3)
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active mutant of AKT (AKT-CA). The expression of AKT-CA
prevented the decrease in phospho-FOXO3 (Thr32) levels 2
and 4 h after GLUT exposure (Figure 2f).
AMPK activation during excitotoxicity induces FOXO3
nuclear translocation. We next analyzed whether the
nuclear presence of FOXO3 was also increased in response
to GLUT. CGNs were transfected with a FOXO3-GFP
plasmid and exposed to either GLUT/GLY (100/10 mM) or
experimental buffer. Confocal images of single neurons were
taken for FOXO3-GFP, Hoechst 33258 and propidium iodide
(PI). Quantification of the GFP fluorescence intensity inside
and outside the nucleus allowed the calculation of a nuclear/
cytoplasmic FOXO3-GFP ratio. In cells exposed to GLUT,
29.3±8.3% of neurons showed a sudden and permanent
increase in this ratio, occurring with a delay that varied
between 1 and 5 h after GLUT exposure (mean delay of 3 h
28±33 min) (Figures 3a and b). Of note, all neurons that
exhibited this sudden and permanent increase underwent
nuclear shrinkage and cell death 7–12 h after GLUT
exposure (mean time-point 9 h 14±56 min), as indicated by
the loss of the GFP fluorescence signal and an increase in PI
fluorescence. The remaining neurons that survived
(62.8±2.1% of the total population) did not show any change
in their nuclear/cytoplasmic ratio, or showed a transient
increase that recovered to baseline levels (mean duration
of ratio increase 1 h 2±7 min) (Supplementary Figures 3A
and B). Cells exposed to experimental buffer only did not
show any alterations in the nuclear/cytoplasmic FOXO-GFP
ratio (Supplementary Figure 3C).
We investigated whether AMPK activation alone was suffi-
cient to induce FOXO3 nuclear translocation. Expression of
0
50
100
150
200
p-AKT(Ser473)
AKT
*
p-mTOR(Ser2448)
mTOR
p-FOXO3(Thr32)
FOXO3
AKT
p-FOXO3(Thr32)
FOXO3
Sham 10’ 30’ 2 h 4 h 8 h 16 h 24 h
Sham 10’ 30’ 2 h 4 h 8 h 16 h 24 h Sham 10’ 30’ 2 h 4 h 8 h 16 h 24 h
Sham 10’ 30’ 2 h 4 h 8 h 16 h 24 h
Time after glutamate treatment 
0
50
100
150
β-Actin
β-Actin
β-Actinβ-Actin
β -Actin
0
50
100
150
*
AMPK siRNA
Control siRNA
AKT-CA
Control plasmid
- - +- + +
--+ -++
- - +- + +
--+ -++
0
50
100
150
p-
FO
X3
O
3
O
pt
ica
l D
en
sit
y
(%
 of
 co
ntr
ol)
p-
AK
T
O
pt
ica
l D
en
sit
y
(%
 of
 co
ntr
ol)
Sham 2 4 Sham 2 4
Sham 1 2 Sham 1 2
0
50
100
150
* *
Time (h) after glutamate treatment
*
*
*
*
0
50
100
150
200
*
* *
O
pt
ica
l D
en
sit
y
(%
 of
 co
ntr
ol)
O
pt
ica
l D
en
sit
y
(%
 of
 co
ntr
ol)
O
pt
ica
l D
en
sit
y
(%
 of
 co
ntr
ol)
O
pt
ica
l D
en
sit
y
(%
 of
 co
ntr
ol)
Time after glutamate treatment 
Time after glutamate treatment Time after glutamate treatment 
Time (h) after glutamate treatment
pAMPKα(Thr172)
p-AKT (Ser473)
AKT
β-Actin
p-FOXO3a (Thr32)
FOXO3a
a b
c d
e f
Figure 2 Downregulation of the mTOR/AKT pathway during excitotoxicity. (a) CGNs exposed to GLUT/ GLY (100/10mM, 30 min) increased phospho Thr172 AMPKa
levels 10–30 min after exposure (*Po0.05; n¼ 3). b-actin served as loading control. (b) GLUT exposure permanently decreased phospho Ser2448 mTOR levels (*Po0.05;
n¼ 3). Total mTOR and b-actin served as loading controls. (c) GLUT reduced phospho Ser473 AKT levels 10 min–2 h after GLUT exposure (*Po0.05; n¼ 4). Total AKT and
b-actin served as loading controls. (d) GLUT reduced phospho Thr32 FOXO3 levels 2 h after GLUT exposure (*Po0.05; n¼ 6). Total FOXO3 and b-actin served as loading
controls. (e) CGNs were transfected with AMPK siRNA or Control siRNA expressing vectors before GLUT exposure. Phospho Ser473 AKT/ Thr32 FOXO3 levels were
analyzed (1 and 2 h) after GLUT exposure. AMPK siRNA neurons presented higher levels than control siRNA neurons at both time-points (*Po0.05; n¼ 3). Total AKT,
FOXO3 and b-actin served as loading controls. AMPK depletion was monitored by quantification of total AMPKa levels (Supplementary Figure 1). (f) CGNs were transfected
with AKT-CA or a control construct before GLUT exposure. AKT-CA neurons presented significantly higher phospho (Thr32) FOXO3 levels than control neurons (2 and 4 h)
after GLUT exposure (*Po0.05; n¼ 3). Total FOXO3 and b-actin served as loading controls. AKT-CA expression was monitored by total AKT levels
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the AMPK-CA construct significantly increased the percen-
tage of neurons showing FOXO3-GFP nuclear presence
when compared with cells transfected with a control vector
(Supplementary Figure 2C).
We next tested whether the nuclear translocation of
FOXO3-GFP during excitotoxic injury was prevented
either by expression of AKT-CA, or by inhibition of AMPK.
We compared the percentage of cells exhibiting nuclear,
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Figure 3 AMPK activation during excitotoxicity induces FOXO3 nuclear translocation. (a–d) CGNs were transfected with a FOXO3-GFP construct. (a) Traces of the
nuclear/cytoplasmic FOXO3-GFP ratio in single CGNs as monitored using time-lapse microscopy. Following treatment with GLUT/ GLY (100/10mM) for 30 min, 29.3±8.3%
of the neurons showed an increase in the nuclear/cytoplasmic FOXO3-GFP ratio, and its persistence was associated with a drop in GFP signal and neuronal death as
indicated by PI uptake. Representative traces are shown. (b) Images extracted from the time-lapse series showing a CGN with FOXO3-GFP only in the cytoplasm at the start
of the time series (1 h), persistent translocation of FOXO3-GFP to the nucleus (4.5 h), shrinkage of the nucleus (6.5 h), and subsequent secondary necrosis (12 h), bar, 10mm.
(c) FOXO3-GFP was co-expressed with the AKT-CA construct or a control vector. In the presence of the control vector, GLUT treatment increased the percentage of neurons
with nuclear FOXO3-GFP (black bars) 3.5 h after exposure, and decreased the percentage with cytoplasmic FOXO3-GFP (white bars) (*Po0.05; n¼ 3). AKT-CA expression
prevented both effects. (d) CGNs were pretreated with CC (10 mM) or vehicle for 45 min before GLUT exposure. CC pretreatment significantly reduced the increase in the
percentage of cells with nuclear FOXO3-GFP (black bars), and the decrease in those with cytoplasmic FOXO3-GFP (white bars), 3.5 h after GLUT exposure (*Po0.05;
n¼ 3). (e) CGNs were exposed to GLUT 48 h after transfection with AMPK siRNA or Control siRNA and were fixed and stained 3.5 h later with Hoechst and an antibody
against FOXO3. AMPK siRNA significantly reduced the GLUT-induced increase in nuclear FOXO3 (black bars) and decrease in cytoplasmic FOXO3 (white bars), confirming
the effects seen in (d) (*Po0.05; n¼ 4). (f) Images of single CGNs transfected with GFP-tagged siRNA and stained with an antibody against FOXO3 (red) and with Hoechst
(blue), showing primarily nuclear (image series on left) or cytoplasmic (image series on right) FOXO3 staining. Bar, 5mM
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cytoplasmic or cytoplasmic and nuclear presence of FOXO3-
GFP 3.5 h after GLUT or vehicle exposure. GLUT exposure
significantly increased the percentage of neurons with
nuclear FOXO3-GFP compared with control neurons, and
decreased the percentage of neurons with cytoplas-
mic FOXO3-GFP (Figures 3c and d). Both effects were
abrogated by AKT-CA expression (Figure 3e) or by pre-
treatment with CC (10mM) (Figure 3d). These results
were confirmed with immunofluorescence experiments on
neurons transfected with AMPK siRNA (Figures 3e and f).
These data demonstrated that excitotoxic injury induces
FOXO3 nuclear translocation in an AMPK- and AKT-
dependent manner.
FOXO3 nuclear translocation is not sufficient for bim
expression and cell death. In addition to FOXO3 nuclear
translocation, further post-translational modifications may be
necessary to stimulate its transcriptional activity.17,22 This
hypothesis was tested by co-expressing the bim promoter
plasmid with a FOXO3 construct, mutated at the AKT
phosphorylation sites and therefore permanently localized
to the nucleus (‘FOXO3-nuclear’21). GLUT/GLY (100/10 mM)
exposure significantly increased luciferase activity in CGNs
expressing ‘FOXO3-nuclear’ (Supplementary Figure 4A),
suggesting that FOXO3 required further post-translational
modifications to increase its binding to the bim promoter.
Additional single-cell experiments implicated AMPK in
mediating these events. Neurons transfected with FOXO3-
GFP were exposed to GLUT, and 2 h later treated with CC
(10mM). We hypothesized that this treatment paradigm
would avoid AMPK inhibition during or shortly after GLUT
exposure, allowing FOXO3 nuclear translocation, but inhibit-
ing AMPK subsequent to this. Indeed, late addition of CC did
not prevent FOXO3-GFP nuclear translocation. However, all
neurons that displayed a permanent FOXO3 nuclear
translocation failed to undergo subsequent nuclear shrinkage
and cell death (Figures 4a and b), and remained viable until
termination of the experiments.
To corroborate these single-cell experiments we analyzed
Bim and FOXO3 expression and localization by western
blotting in CGNs treated with CC 2 h after GLUT exposure.
CC-treated neurons expressed lower levels of Bim, without a
decrease in FOXO3 nuclear translocation (Figures 4c and d).
GLUT-induced cell death was also significantly impaired in
this setting (Figure 4e). Taken together, this data suggest that
AMPK may have a further essential role in bim activation that
extends beyond inducing FOXO3 translocation, and that
requires prolonged AMPK activity.
We also investigated FOXO3 translocation and Bim
expression during varied durations of pharmacologically-
induced AMPK activity. We found that although CGNs
subjected to continuous AICAR treatment (2.5 mM) showed
increased Bim expression, no significant Bim induction
occurred with transient addition of AICAR to the cultures for
1 h despite FOXO3 nuclear translocation in both treatment
paradigms. Increased nuclear localization of pAMPK was also
observed after continuous, but not transient, AICAR treatment
(Figure 4f), confirming that prolonged AMPK activation is
required for Bim expression, and suggesting that nuclear
pAMPK may mediate this Bim expression.
FOXO3 activation by AMPK is a coherent feed-forward
network motif that can act as a suppressor of transient
stress signals. To understand the regulatory role of AMPK
in FOXO3 activation and Bim expression from a systems
point of view, we employed computational modeling. Initially,
we modeled (by ordinary differential equations) a one-step
FOXO3 activation where pAMPK-mediated Akt inhibition
lead to FOXO3 dephosphorylation (FOXO3dephos) and
activated FOXO3 for Bim expression (Figure 5a, denoted
by (1)). This ‘linear’ pathway predicted a similar FOXO3
activation, and therefore Bim expression, following both
short-term and long-term periods of AMPK activity
(Figure 5b). However, this linear model neither explained
our results that the duration of AMPK activation may
determine whether Bim is expressed or not (Figure 4f), nor
did it support previous findings that short-term pAMPK
activation was neuroprotective.11,23 We therefore assumed
that an additional regulation step was required to prevent Bim
expression following short-term AMPK activation, while
maintaining robust Bim expression following prolonged
AMPK activation.
We incorporated into our model a second activation step of
FOXO3dephos by pAMPK (‘FOXO3ampk’) (Figure 5a, dashed
line denoted by (2)). In this model, Bim induction was
suppressed for short-term pAMPK activity (Figure 5c,
40 min), as the pAMPK signal (second activation step) was
no longer active by the time the signal of the first activation
step had induced FOXO3 dephosphorylation. Prolonged
pAMPK activation, however, outlasted the delay of the first
step and led to a pronounced increase in Bim expression
(Figure 5c, 100 min). This gave a qualitatively good explana-
tion of our findings in Figure 4f, where long-term AMPK
activation led to significant Bim expression, whereas short-
term activation did not. The inclusion of a second FOXO3
activation step by pAMPK resulted in a network motif known
as a coherent feed-forward loop (CFL).
AMPK induces bim expression by direct FOXO3 phos-
phorylation. AMPK has been shown to regulate the DNA
binding of transcription factors by direct phosphoryla-
tion.10,24,25 Interestingly, in non-neuronal cells, AMPK has
been shown to specifically activate FOXO3 by phosphoryla-
tion.24 To validate the modeling results we tested if AMPK
phosphorylation of FOXO3 was required for Bim expression.
We co-expressed a FOXO3 construct (FOXO3-6A), which is
mutated at the six residues (Thr179, Ser399, Ser413,
Ser439, Ser555 and Ser588) phosphorylated by AMPK,
alongside the bim promoter reporter plasmid. As expected,
CGNs co-transfected with FOXO3 wt and treated with GLUT
showed a significant increase in luciferase activity compared
with control neurons. However, in neurons co-transfected
with the FOXO3-6A mutant, this effect was abrogated
(Figure 6a, upper panel). These results were also confirmed
by western blot analysis of Bim protein levels (Figure 6a,
lower panel).
Next we tested whether FOXO3 translocation during
excitotoxicity also required FOXO3 phosphorylation by
AMPK. CGNs were transfected with FOXO3-6A or FOXO3
wt constructs and then exposed to GLUT or experimental
buffer. Three hours after exposure cultures were subjected to
FOXO3 and AMPK
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subcellular fractionation. GLUT treatment induced a similar
increase in FOXO3 wt and FOXO3-6A nuclear levels when
compared with control neurons (Figure 6b). A similar
decrease was observed in cytosolic FOXO3 wt and
FOXO3-6A levels (Flag M2-tag), suggesting that FOXO3
phosphorylation by AMPK did not affect FOXO3 translocation.
We also observed that pAMPKa (Thr172) levels were
increased in the nucleus and decreased in the cytosol after
GLUT treatment (Figure 6b), suggesting the nuclear trans-
location of both pAMPK and FOXO3 during excitotoxicity. The
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fact that nuclear pAMPK is enriched 3 h after GLUT exposure
indicates that FOXO3 phosphorylation by AMPK can occur
subsequent to FOXO3 nuclear translocation. We next directly
tested whether the phosphorylation state of FOXO3 in the
nucleus depended on AMPK activity. CGNs transfected with
the ‘FOXO3-nuclear’ mutant were pretreated with CC (10mM)
and later exposed to GLUT. Four hours later, we detected
elevated levels of ‘FOXO3-nuclear’ serine phosphorylation in
neurons exposed to GLUT when compared with controls. This
effect was abrogated in neurons pretreated with CC
(Figure 6c).
The above results showed that FOXO3 phosphorylation by
AMPK increased bim promoter activation during excitotoxic
injury. This phosphorylation was specific to the bim promoter,
as FOXO3-6A expression did not affect the activation of a
chimeric promoter bearing six canonical FOXO-binding
elements (TTGTTTAC box) not present in the bim promoter
(Supplementary Figure 4B). We next tested if inhibition of
FOXO3 phosphorylation by AMPK could facilitate the activa-
tion of alternative FOXO3 targets, such as the promoter of the
stress tolerance gene MnSOD.22 A FOXO3 wt or a FOXO3-
6A construct were co-expressed with a luciferase reporter
plasmid containing the MnSOD promoter sequence (pSOD-
luc) in CGNs. GLUT exposure increased luciferase activity in
control neurons transfected with FOXO3 wt (Figure 6d).
However, FOXO3-6A expression increased luciferase activity
in neurons exposed to either experimental buffer or GLUT.
This effect was abrogated by mutation of the FOXO3 binding
sites in the MnSOD promoter (pSOD-luc-mut) (Figure 6d).
FOXO3 activation by AMPK is required for cell death.
Next, we analyzed whether inhibition of FOXO3 phosphor-
ylation by AMPK decreased neuronal injury during excito-
toxicity (Figure 7a). We co-transfected CGNs with a GFP-
expressing plasmid and either the FOXO3 wt, dominant-
negative FOXO3 (DN-FOXO3), or FOXO3-6A expression
plasmid. Cell death was determined by evaluating the
percentage of PIþ and GFPþ cells before and 16 h after
GLUT/GLY (100/10 mM) exposure. As shown in Figure 7a,
FOXO3 wt-transfected neurons treated with GLUT showed
significantly higher levels of cell death than neurons exposed
to vehicle. However, cell death was negligible in cells
transfected with DN-FOXO3 or FOXO3-6A.
To explore the possible relevance of FOXO3 regulation by
AMPK in ischemic neuronal death, we subjected primary
mouse cortical neurons to oxygen/glucose deprivation
(OGD)-induced neuronal injury. Neurons were co-transfected
with a GFP expression vector and either DN-FOXO3, or
FOXO3-6A expression constructs. Cultures were subjected
to OGD for 30 min in a hypoxia chamber, and subsequently
returned to normoxic/normoglycemic conditions for 24 h.
Cell death was determined by evaluating the percentage of
pyknotic nuclei in the GFPþ cells. As shown in Figure 7b,
transfection with FOXO3-6A led to significantly lower levels of
cell death when compared with cells co-transfected with a
control plasmid, an effect that was comparable to the effect of
DN-FOXO3.
Discussion
The present study describes the pro-apoptotic activity of the
energy sensor AMPK during excitotoxic injury. Although
AMPK activation has been associated with cell survi-
val,11,23,26 it is now evident that it is also involved in long-
term cell fate decisions. AMPK activation has been shown to
activate apoptosis in different cell types,27,28 including
neurons,9,13 and this apoptosis occurs after prolonged
periods of AMPK activation.27,28 AMPK has also been shown
to mediate ischemic neuronal death in vivo.14 As apoptosis is
a terminal cellular decision, the signaling pathways controlling
the pro-apoptotic activities of AMPK require a complex
regulation. We here demonstrate that the combined activation
of AP-1 and FOXO3 transcription factors by AMPK is required
for the transcriptional activation of the pro-apoptotic bim gene.
Indeed, bim activation and cell death induction required both
AMPK-dependent FOXO3 nuclear translocation and direct
FOXO3 phosphorylation by AMPK. Systems analysis and
computational modeling showed that this two-step activation
of FOXO3 provides a means for filtering out effects of short-
term AMPK activation on bim induction, while providing robust
bim activation following prolonged AMPK activity.
Previous work from our group has demonstrated that AMPK
mediates cell death by expression of the pro-apoptotic BH3-
only proteins Bim and, in some cell types, Bmf.13,29 Bim
promoter mutation of either the FOXO3 or the AP-1 binding
site prevented bim activation in neurons during excitotoxicity.
We demonstrate that in addition to the engagement of multiple
transcription factors, individual transcription factors may also
be subject to additional post-translational control steps in
order to efficiently activate bim transcription. We observed
that AMPK transiently inhibited AKT signaling during excito-
toxicity, and that AKT-mediated FOXO3 dephosphorylation
was a key step that allowed the nuclear translocation of
FOXO3.21 This translocation was permanent in neurons,
which underwent apoptosis, and was transient or did not
occur in surviving cells. Specific mechanisms must therefore
Figure 4 FOXO3 nuclear translocation is not sufficient for bim expression and cell death. (a) Traces of the FOXO3-GFP ratio in single CGNs exposed to GLUT and 2 h
later treated with CC (10 mM). In this case, all neurons that suffered a persistent FOXO3 nuclear translocation did not suffer subsequent nuclear shrinkage or cell death until
termination of experiment. Representative traces are shown. (b) Images extracted from the time-lapse series showing a CGN with FOXO3-GFP in the cytoplasm at the start of
the time series (1 h), persistent translocation of FOXO3-GFP to the nucleus (6 h), no shrinkage of the nucleus (12 h), and no subsequent secondary necrosis (16 h), bar,
10mm. (c) CC (10mM) addition 2 h after GLUT exposure significantly reduced the GLUT-induced increase in Bim expression (measured 8 h after GLUT exposure, *Po0.05;
n¼ 3). b-actin served as loading control. (d) CC (10mM) addition 2 h after GLUT exposure did not prevent the GLUT-induced decrease in cytoplasmic (cyto) FOXO3 or
increase in nuclear FOXO3 levels (measured 8 h after GLUT exposure, *Po0.05; n¼ 4). b-actin and Neu-N served as loading controls. (e) Addition of CC (10mM) 2 h after
GLUT treatment significantly reduced the % of PIþ cells detected 16 h after the excitotoxic insult (*Po0.05; n¼ 3). (f) CGNs exposed to continuous AICAR (2.5 mM)
treatment showed an upregulation of Bim levels in the cytosol, and pAMPK (Thr172) a and FOXO3 levels in the nucleus (*Po0.05; n¼ 3). CGNs exposed to transient AICAR
treatment (2.5 mM, 1 h, then washout) also showed increased nuclear FOXO3 levels; however, Bim levels in the cytosol and pAMPK in the nucleus were not upregulated
(n¼ 3). b-actin and Neu-N served as loading controls. Times (h) indicate duration of AICAR treatment (continuous) or recovery times following washout of AICAR
FOXO3 and AMPK
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exist to restore pAKT/pFOXO3 levels in surviving neurons.
Survival responses during excitotoxicity have been asso-
ciated with enhanced neuronal glucose uptake and ATP
availability, as well as with growth factor signaling,9,12
suggesting that these factors could restore pAKT/pFOXO3
levels. The persistent mTOR dephosphorylation after GLUT
exposure suggests the involvement in this process of other
AKT regulators besides mTOR. Given the central role of AKT
in several cell survival pathways such as PI3K and GSK-3b
signaling,30 the regulation of AKT independently from mTOR
and AMPK pathways is not surprising and may involve
phosphatases such as PP2A or PTEN.31,32
The AKT-dependent nuclear translocation of FOXO3,
however, was not the sole determinant of FOXO3-dependent
bim gene expression. Both biochemical and single-cell
imaging experiments, as well as experiments using FOXO3-
6A, demonstrated that bim activation and cell death addition-
ally required FOXO3 phosphorylation by AMPK. In contrast,
the transcription of the MnSOD promoter was stimulated by
FOXO3-6A expression alone. This finding suggested that
direct phosphorylation by AMPK could guide FOXO3 towards
its binding to the bim promoter instead of towards others
targets such as the MnSOD promoter.
The two-step activation of FOXO3 by AMPK is a CFL
network motif. Well established in systems biology, and
overrepresented in pathways of gene regulation, CFLs are
known to induce gene expression upon sustained, but not
transient signals.33,34 Indeed, our identified CFL enables the
filtering of transient AMPK impulses so that shorter periods of
AMPK activity do not lead to Bim induction and allow pAMPK
to exert its pro-survival effects.11 This filtering is achieved by
the delay required for the AKT-mediated FOXO3 depho-
sphorylation in the first activation step. The period of AMPK
activity must outlast this delay to activate FOXO3 in the
second activation step. Increased survival signaling, through
AKT activation, would prolong the delay of the first activation
step, requiring a longer period of AMPK activity to induce Bim
expression. This idea is supported by evidence showing a
reduction in apoptosis following stimulation of AKT.35 Conse-
quently, the CFL of FOXO3 activation may regulate Bim
expression based on both stress duration and the extent of
pro-survival signaling.
Previously, we demonstrated the involvement of JNK in Bim
expression and the nuclear translocation of C-JUN induced by
AMPK during excitotoxicity.13 Neurons have high levels of
constitutive JNK1 activity,36 so it remains to be shown whether
any surplus activation of JNK by AMPK contributes to bim
gene induction during excitotoxic apoptosis. Such a potential
third activation step by AMPK cannot be excluded, and may
integrate other stress-related signals to form a more complex
cascade of CFLs. Oxidative stress, for example, may activate
the JNK/AP-1 pathway.36 Similarly, we cannot exclude a role
of other transcription factors, such as Myb,18 in bim activation.
Additionally, the FOXO family of transcription factors may be
subject to other post-translational modifications such as JNK
phosphorylation or SIRT1 de-acetylation.22,37
AMPK has previously been shown to control the DNA-
binding of different transcription factors or co-factors by
phosphorylation.10,24,25 AMPK phosphorylation of FOXO3
was not required for its nuclear translocation (see also
Greer et al.24). However, it is possible that FOXO3 dephos-
phorylation and its subsequent nuclear translocation is a
requirement for subsequent post-translational modifications
(that is, FOXO3 phosphorylation by AMPK).17 Indeed, this is a
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Figure 5 FOXO3 activation by AMPK is a coherent feed-forward network motif
that can act as a suppressor of transient stress signals. A second activation step of
FOXO3 is necessary to explain neuronal tolerance to short-term pAMPK activity
while maintaining Bim expression following prolonged pAMPK activity. (a) pAMPK-
mediated FOXO3 activation was initially modeled by a linear pathway (denoted by
(1)). (b) This linear pathway predicted similar Bim expression patterns following
short- and long-term periods of pAMPK activity and conflicted with recent findings of
the neuroprotective role of pAMPK.11 (c) Incorporation of the second activation step
(denoted by (2) in (a)) reduced Bim expression following short-term pAMPK activity
(40 min, gray bars). This network structure represents a CFL and, by preventing Bim
expression in times of short-term stress, may allow pAMPK to exert its pro-survival
effects. Significant Bim expression is still present following long-term pAMPK activity
(100 min, black bars). Bars indicate relative differences in expression levels
between both scenarios
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necessary condition for the functioning of the proposed CFL.
We provided evidence of nuclear effects of AMPK on FOXO3
with Bim induction only detected after sustained AMPK
activation and nuclear presence of pAMPKa. Shorter periods
of AMPK activity did not lead to AMPK translocation or Bim
expression, although FOXO3 nuclear translocation was
maintained in both scenarios. This evidence suggested that
interaction of FOXO3 and AMPK in the nucleus could be a
requirement for bim promoter activation and apoptosis.
Interestingly, neuronal apoptosis was recently described in a
model of Huntington’s disease as dependent on nuclear
accumulation of AMPK-a1.38
In conclusion, our data suggest that FOXO3 activation
represents a key step during bim-mediated excitotoxic
neuronal death. The complex interplay between cellular
bioenergetics, AMPK activation, and mTOR/AKT/FOXO3
signaling provides a molecular framework for cell fate decision
making, preventing unwanted apoptosis activation during
physiological AMPK activation or during conditions of mild
bioenergetic stress.
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Figure 6 AMPK induces bim expression by direct FOXO3 phosphorylation. (a) Upper. CGNs were co-transfected with a vector containing the bim promoter and either
the wt FOXO3 or FOXO3-6A constructs. GLUT/GLY (100/10mM, 30 min) exposure significantly increased bim promoter activation in cells transfected with FOXO3 wt
(*Po0.05; n¼ 4). FOXO3-6A expression prevented this effect (*Po0.05; n¼ 4). (a) Lower. Western blot analysis confirmed the effect of FOXO3-6A on Bim protein
levels after GLUT exposure (30 min). Results are representative of two independent experiments. (b) Upper. Nuclear fraction of CGNs transfected with FOXO3-Flag wt
or FOXO3-6A-Flag constructs. Flag-tag detection by western blot and densitometry analysis showed a similar upregulation of both constructs 4 h after GLUT exposure
(*Po0.05; n¼ 4). Nuclear phospho (Thr172) AMPKa levels were also upregulated. Neu-N was used as nuclear marker and b-actin as loading control. (b) Lower. GLUT
exposure downregulated levels of FOXO3 wt and FOXO3-6A. Cytoplasmic phospho (Thr172) AMPKa levels were also downregulated. b-actin served as loading control.
Representative blots are shown. (c) CGNs transfected with a ‘FOXO3-nuclear’ mutant (tagged with a flag-HA) and immunoprecipated showed an increase
in Ser-phosphorylation 4 h after GLUT exposure (*Po0.05; n¼ 3). Pre-treatment with CC (10 mM) for 45 min abrogated this effect (*Po0.05; n¼ 3). (d) CGNs were
co-transfected with a luciferase reporter containing a MnSOD promoter sequence (pSOD-luc) and either wt FOXO3 or FOXO3-6A. GLUT exposure increased luciferase
activity in cells transfected with FOXO3 wt. However, FOXO3-6A expression increased luciferase activity in neurons exposed to experimental buffer or GLUT. This effect
was abrogated by mutation of the FOXO3 binding sites in the MnSOD promoter (pSOD-luc-mut) (*Po0.05; n¼ 4)
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Materials and Methods
Materials. Fetal calf serum and minimal essential medium were obtained
from Invitrogen (Bio Sciences, Dublin, Ireland). GLUT, GLY, Hoechst 33258 and
PI were from Sigma-Aldrich (Arklow, Ireland). AICAR was from Cell Signaling
(Isis Ltd, Bray, Ireland). CC was obtained from Calbiochem (Merck Biosciences,
Nottingham, UK).
Preparation of primary CGNs. Both mouse (C57BL) or rat (Sprague–
Dawley) cerebella were isolated from postnatal day 7 pups. CGN cultures were
obtained as described previously.7 Cells were plated on poly-Lysine-coated glass
coverslips, glass Willco dishes, 6-well plates, and 24-well plates at 1 106 cells/ml,
and maintained at 37 1C in a humidified atmosphere of 5% CO2/ 95% air.
Experiments were performed after 8–10 days in vitro. All animal work was
performed with ethics approval from the RCSI and under licenses granted to the
authors by the Irish Department of Health and Children.
Plasmids, siRNA and transfection. The FOXO3-GFP plasmid in an
EGFP-N1 vector backbone was kindly provided by MP Smidt (University Medical
Center, Utrecht, The Netherlands). The AMPK-CA construct is the truncated
version of AMPKa1 after residue 312 and includes a Myc tag and was a kind gift
from David Carling (Imperial College London, London, UK). The AKT-CA construct
expresses the myristoylated AKT-1 sequence and was kindly provided by S Pons
(Biomedicine Institute, CSIC, Barcelona, Spain). The Firefly luciferase reporter
plasmid containing 0.8 kB of the bim promoter sequence along with similar
constructs with mutated FOXO3 or AP-1 binding sites were kindly provided by Eric
Lam (Imperial College London, London, UK). The pECE-FOXO3-TM (termed here
‘FOXO3-nuclear’), a construct mutated at the three sites (T32A/S253A/S315A) of
AKT phosphorylation and permanently located in the nucleus, was kindly provided
by ME Greenberg (Harvard Medical School, Boston, MA, USA). The pECE-
FOXO3-M2-flag and pECE-FOXO3-6A-M2-flag (sextuple mutant T179A/S339A/
S413A/S555A/S588A/S626A at the sites for AMPK phosphorylation) were kind
gifts from A Brunet (Harvard Medical School). The pmax-GFP construct was
obtained from LONZA (Basel, Switzerland). The pRL-TK (TK Renilla luciferase),
the 6DBE FOXO3 (reporter luciferase plasmid with six copies of the FOXO
family protein-binding element) and the reporter plasmids containing the MnSOD
promoter sequence (pSOD-luc) along with a similar construct with mutated
FOXO3 binding sites (pSOD-luc-mut) were a kind gift from BM Burgering
(University Medical Center, Utrecht, The Netherlands). The DN-FOXO3 expresses
the DNA-binding domain (amino acids 141–268) of pECE-FOXO3-TM, and
was kindly provided by I Torres-Aleman (Cajal Institute, CSIC, Madrid, Spain).
siRNA targeting AMPK-a1/a2 (pFIV-AMPK-siRNA) and the control sequence
(pFIV-Control-siRNA) were previously described.11 CGNs were transfected using
calcium phosphate as previously described,11 the transfection reagent Neurofect
from Genlantis (AMS Biotechnology, Milton, UK), or an electroporation kit
(LONZA) as per manufacturer’s instructions.
Live cell microscopy. CGNs on glass Willco dishes (WillCo Wells BV,
Amsterdam, The Netherlands) were transfected with a FOXO3-GFP construct.
After 48 h cells were treated for 30 min with GLUT and GLY (100mM and 10mM)
in experimental buffer (120 mM NaCl, 3.5 mM KCl, 0.4 mM KH2PO4, 20 mM
HEPES, 5 mM NaHCO3, 1.2 mM Na2SO4, 1.2 mM CaCl2, 1.2 mM MgCl2 and
15 mM glucose; pH 7.4). Control CGNs were treated with experimental buffer only.
Next, CGNs were stained with Hoechst 33258 and PI at a final concentration of
0.1mg/ml. Following treatment, the pre-conditioned medium, supplemented with
HEPES (final concentration 20 mM), was replaced onto the cells and the dish was
placed on the stage of a confocal microscope equipped with a 63 1.4 NA oil
immersion objective and a thermostatically regulated chamber at 37 1C (LSM 710,
Carl Zeiss, Jena, Germany). A thin layer of mineral oil (1.5 ml) was added onto the
medium to prevent evaporation. GFP was excited at 488 nm with an Argon laser
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Figure 7 FOXO3 activation by AMPK is required for cell death. (a) CGNs were
co-transfected with GFP and either the FOXO3 wt, DN-FOXO3 or FOXO3-6A
expression plasmid. FOXO3 wt-transfected neurons treated with GLUT showed a
significantly higher percentage of cell death (31.4±3.8% of total cells) than neurons
exposed to vehicle (6.4±2.7%) 16 h after GLUT/GLY (100/10mM, 30 min)
exposure. However, cell death after the excitotoxic insult was negligible in cells
transfected with DN-FOXO3 or FOXO3-6A, which presented a significant decrease
in the percentage of cell death compared with FOXO3 wt-transfected neurons
(*Po0.05; n¼ 3). (b) Cortical neurons were co-transfected with a GFP-expression
vector and either AMPK siRNA, DN-FOXO3 or FOXO3-6A expression constructs.
After 72 h transfection cultures were subjected to OGD (30 min) in a hypoxia
chamber, and returned to normoxic/normoglycemic conditions. Cell death was
determined 24 h later by evaluating the percentage of pyknotic nuclei in the GFPþ
cells following Hoechst staining. Expression of either FOXO3-6A or DN-FOXO3
significantly reduced the percentage of neuronal cell death (13.0±7.8% and
12.0±7.8% of total cells, respectively) compared with cells co-transfected with a
control plasmid (31.6±4.6%) (*Po0.05; n¼ 4). Bar, 10mM
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(AOTF set to 0.5%) and the emission collected in the range of 493–552 nm.
Hoechst 33258 was excited at 405 nm (1% transmission, ND filter and AOTF) and
the emission detected in the range of 410 to 480 nm. For the detection of plasma
membrane permeabilization PI was excited at 543 nm (AOTF 1.5% transmission)
and fluorescence emission was detected above 570 nm. Images were captured at
5 min intervals at 1.5mm optical slice thickness. The resulting images were
processed using MetaMorph 7.5 software (Molecular Devices, Wokingham, UK).
The GFP average intensity fluorescence signal was quantified at the nucleus and
cytoplasm to determine the nuclear/cytoplasmic FOXO3-GFP ratio. At least 33
single-cell experiments were analyzed for cells treated with GLUT, and 6 for those
treated with experimental buffer. For quantification of FOXO3 nuclear translocation
in neuronal populations, CGNs were plated on 24-well plates. At 3.5 h after GLUT/
experimental buffer exposure, neurons were incubated for 30 min with Hoechst
33258 (final concentration 1 mg/ml) and PI (final concentration 0.2mg/ml). For each
group, 80–90 cells were analyzed in three independent experiments using an
Eclipse TE 2000s inverted microscope (Nikon, Amstelveen, The Netherlands) and
a 40 0.6 NA objective. Images of GFP, PI and Hoechst signals of single
neurons were taken and processed with Image J software (NIH, Bethesda, MD,
USA) to determine the nuclear/cytoplasmic FOXO3-GFP ratio. Neurons were
scored as follows: FOXO3-GFP cytoplasmic (ratio o0.9), FOXO3-GFP nuclear
(ratio 41.1), FOXO3-GFP cytoplasmic/nuclear (0.9oratioo1.1).
Western blotting and immunoprecipitation. Western blotting was
performed as described.11 Neurons were lysed with PIK buffer (1% NP-40,
150 mM NaCl, 20 mM Tris, pH 7.4, 10% glycerol, 1 mM CaCl2, 1 mM MgCl2,
400mM sodium vanadate, 0.2 mM PMSF, 1 mg/ml leupeptin, 1 mg/ml aprotinin,
0.1% phosphatase inhibitor cocktails I and II of Sigma-Aldrich). Blots were probed
with rabbit polyclonal antibodies to Bim (H-191) and HA (Y-11) from Santa Cruz
Biotechnology (Dublin, Ireland). Phospho (Thr172) AMPKa antibody, total AMPKa,
phospho (Thr183/Thr185) JNK, total JNK, phospho (Ser473) AKT, total AKT,
phospho (Ser63) c-Jun, phospho (Ser2448) mTOR total mTOR, phospho (Ser253)
FOXO3 and phospho (Thr32) FOXO3 all from Cell Signaling and anti-Myc tag and
total FOXO3 antibodies from Millipore (Carrigtwohill, Ireland). Blots were also
probed with mouse monoclonal antibodies to b-actin (clone DM 1A) and Anti-flag
M2 from Sigma-Aldrich, and Neu-N and Anti-Phosphoserine clone 4A4 from
Millipore. Horseradish peroxidase-conjugated secondary antibodies from Thermo
Scientific (Fisher, Dublin, Ireland) were detected using SuperSignal West Pico
Chemiluminescent Substrate (Thermo Scientific) and imaged using a FujiFilm
LAS-3000 imaging system (FujiFilm, Dublin, Ireland). To normalize for protein
load, membranes were reblotted (Re-Blot, Millipore) and incubated with an
appropriate control antibody. Levels of the protein under study were expressed
relative to protein load in each lane as determined by appropriate control protein
content. pAMPKa levels were normalized to b-actin, as GLUT treatment
decreased total AMPK levels. Densitometry analysis was performed using Image J
software (NIH). A representative blot is shown from a total of at least three
independent experiments, except where indicated. Immunoprecipitation was
performed in cultured neurons lysed in PIK buffer and centrifuged at 22 000 g
for 20 min, and supernatants were incubated with antibodies bound to 25%
agarose (Santa Cruz Biotechnology) overnight. The immunoprecipitates were
washed three times with the same lysis buffer, resuspended in 2.5 SDS loading
buffer and analyzed by western blot.
Cytosolic and nuclear fractionation. Nuclear and cytosolic fractions
were obtained from total neuronal lysates as described.39 The quality of the
fractionation was determined by assaying for the presence of the nuclear protein
Neu-N.
Cell death assays. CGNs were cultured on 24-well plates. For determination
of apoptotic morphology cells were stained live with Hoechst 33258 at a final
concentration of 1 mg/ml. After incubation for 10 min, nuclear morphology was
observed and cells with condensed nuclei were scored as pyknotic and expressed
as a percentage of the total population. For determination of neuronal mortality
cells were transfected with a pMax-GFP and different constructs under evaluation
in a 1 : 5 ratio. GFP-positive cells (GFPþ cells) were counted before treatment to
determine the baseline level of transfected cells at time-point 0, and were counted
again 2 h after treatment. Results were expressed as percentage of GFPþ cells at
time 0. Neurons were counted in 12 different fields using an Eclipse TE 300
inverted microscope (Nikon) and a 20 0.45 NA objective. All assays were done
in triplicate in at least three independent experiments.
Luciferase assays. CGNs were transfected with luciferase reporter constructs
containing different promoters along with a Renilla luciferase expression plasmid
(pRL-TK) for normalization. Neurons were lysed in passive lysis buffer and
luciferase activity was analyzed using a luminometer and dual luciferase assay kit
according to the manufacturer Promega (Medical Supply, Dublin, Ireland).
Transfections were performed in triplicate dishes and relative luciferase counts
were normalized using TK Renilla luciferase co-transfection. Background
luminescence was subtracted, and Luciferase activity was expressed as fold of
the increase with respect to the control.
Immunocytochemistry. Following treatment, CGNs cultured on glass
coverslips were fixed (3% paraformaldehyde), permeabilised (0.1% Triton x-100
in PBS), blocked (5% horse serum (Invitrogen Bio Sciences), 0.3% Triton x-100 in
PBS) and incubated with an antibody against FOXO3 (Millipore), at room
temperature for 2 h. FOXO3 staining was detected with an anti-rabbit Alexa-
Fluor-568-conjugated secondary antibody (Invitrogen Bio Sciences). Nuclei were
also stained with Hoechst 33258. CGNs were imaged on the LSM 710 micro-
scope detailed above and excited using 561, 488 and 405 nm lasers. Images were
analyzed using ImageJ. The cytoplasmic and nuclear FOXO3 average intensity
was quantified and CGNs were scored as cytoplasmic, nuclear or cyto/nuclear as
described above.
Gene targeted mice. The generation and genotyping of bim / mice has
been previously described.40 The bim / mice were originally generated on a
mixed C57BL/6 129SV genetic background, using 129SV-derived ES cells, but
had been backcrossed for 412 generations onto the C57BL/6 background.
Oxygen and glucose deprivation in cortical neurons. Cortical
neurons cultured on 24-well plates were transfected with a pMax-GFP plasmid and
different constructs under evaluation in a 1 : 5 ratio. Before OGD induction, cells
were rinsed in pre-warmed glucose-free media and transferred to the anaerobic
chamber. The anaerobic chamber had an atmosphere consisting of 1.5% O2, 5%
CO2 and 85% N2. Cells were incubated in OGD media consisting of 2 mM CaCl2,
125 mM NaCl, 25 mM NaHCO3, 2.5 mM KCl, 1.25 mM NaH2P04, 2 mM MgSO4
and 10 mM Sucrose and had a pH of 7.4. After 30 min of OGD, cells were returned
to normoxic conditions containing 21% O2 and 5% CO2. Control cells remained in
normoxic conditions throughout. After 24 h cells were stained live with Hoechst
33258 and cell death assessed as described above.
Computational modeling. We modeled the AMPK-dependent FOXO3
activation by translating the reaction networks shown in Figure 5a into Ordinary
Differential Equations. As model input, different activation profiles of AMPK
(pAMPK) were resembled by a Gaussian curve with a maximum of 270 nM at a
reference time-point and full-width-half-maxima between 0 and 150 min to mimic
transient and prolonged activation. In a first activation step, phosphorylated AMPK
(pAMPK) was assumed to inhibit mTOR and AKT activity, leading to
dephosphorylation of FOXO3 (FOXO3dephos). In a second activation step
(Figure 5a (2)), pAMPK directly phosphorylated FOXO3dephos to a fraction
(FOXO3AMPK) assumed to be capable of inducing bim transcription. The reaction
network is depicted in Supplementary Table 1. Protein–protein interactions,
including all phosphorylation and dephosphorylation events, were modeled by
mass action kinetics, whereas a Hill kinetic was assumed for bim transcription.
First-order degradation kinetics were assumed for dephosphorylated proteins.
Phosphorylated protein fractions were assumed to recover to a steady-state level.
The complete Matlab code is available by request from the authors.
Statistical analysis. Data are expressed as mean±S.D. Differences among
groups were analyzed by one-way ANOVA followed by Tukey test. Comparison
between two groups was performed with the t test. Po0.05 was considered significant.
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